Clinical Trials Browser

Hormone Sensitive Prostate Cancer

Breast Neoplasms

HER2 Negative Breast Cancer

Castrate Sensitive Prostate Cancer

Breast Neoplasms

Breast Neoplasms, Sexual Dysfunctions, Psychological

Breast Neoplasms

PSA Level Greater Than Two

Prostatic Neoplasms

Advanced Breast Cancer

Breast Neoplasms, Breast Neoplasms, Male

Stage I Prostate Adenocarcinoma AJCC v7

Prostatic Neoplasms

Prostatic Neoplasms

Prostate Adenocarcinoma

Breast Neoplasms

Prostatic Neoplasms

Prostatic Neoplasms

Prostate Adenocarcinoma

Neoplasm Metastasis, Prostatic Neoplasms

Salivary Gland Neoplasms, Bulbo-Spinal Atrophy, X-Linked

Breast Neoplasms

Salivary Gland Neoplasms

Prostatic Neoplasms

Breast Neoplasms

Anatomic Stage I Breast Cancer AJCC v8

Prostatic Neoplasms

Prostatic Neoplasms

Hypertension, Kidney Diseases, Prostatic Neoplasms, Primary Dysautonomias

Prostatic Neoplasms

Prostatic Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms, Breast Neoplasms, Male

Prostatic Neoplasms

Neoplasm Metastasis, Prostatic Neoplasms

Prostatic Neoplasms

Prostatic Neoplasms

Prostatic Neoplasms

Breast Neoplasms, Hereditary Sensory and Autonomic Neuropathies

Breast Neoplasms, Patient Compliance

Salivary Gland Neoplasms

Prostatic Neoplasms

Breast Neoplasms

Prostatic Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Prostatic Neoplasms

Clinical Trials

Nivolumab + Docetaxel + ADT in mHSPC Patients With DDRD or Inflamed Tumors

[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer

SELECT

Neoadjuvant Androgen Deprivation Therapy Combined With Enzalutamide and Abiraterone Using Multiparametric MRI and 18FDCFPyL PET/CT in Newly Diagnosed Prostate Cancer

preEMBER

BRE-06: Study to Increase Tolerance to Aromatase Inhibitors for Patients With Early-Stage Hormone Receptor Positive Breast Cancer Who Developed Hypoactive Sexual Desire Disorder

A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With HR+, HER2- Advanced Breast Cancer

Hormone Therapy and Intensity-Modulated Radiation Therapy in Treating Patients With Metastatic Prostate Cancer

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

A Study of Lerociclib in Participants With Advanced Breast Cancer

Adjuvant WIDER

Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery

Testing the Addition of Darolutamide to Hormonal Therapy (Androgen Deprivation Therapy [ADT]) After Surgery for Men With High-Risk Prostate Cancer, The ERADICATE Study

Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial

Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial

Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic

DIVINE

High-Dose Brachytherapy in Treating Patients With Prostate Cancer

Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate Cancer

VA STARPORT

Darolutamide in Patients With Androgen Receptor-Positive Salivary Gland Carcinoma (DISCOVARY)

Roll-over Study to Allow Continued Access to Ribociclib

Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular Typing

THUNDER

CARABELA

Evaluation of Alternative Site Goserelin Acetate Injection for Ovarian Function Suppression (OFS) in Local and Locally Advanced Premenopausal Hormone Receptor Positive Breast Cancer Patients

Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer

Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer

ARCH

Neo-DAB: Darolutamide and Abemaciclib in Prostate Cancer

Finite Androgen Ablation With or Without Abiraterone Acetate and Prednisone in Treating Patients With Recurrent Prostate Cancer

Assessing the Efficacy and Safety of Anti-HER2 Therapy in Nigerian Women With HER2+ Breast Cancer Before and After Surgery

Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS Trial

PETREMAC

e3

CASPAR

Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland

Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer

NePtune

Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer

BYLieve

RWE About QOL and Compliance of Patients With OFS in China

Androgen Deprivation Therapy (ADT) and Pembrolizumab for Advanced Stage Androgen Receptor-positive Salivary Gland Carcinoma

STEEL

PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer

Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate Cancer

Efficacy and Safety of Ribociclib in Pre- and Postmenopausal Chinese Women With HR Positive, HER2-negative, Advanced Breast Cancer.

EVANGELINE

AMALEE

Pembrolizumab With Androgen Deprivation Therapy and Radiotherapy for the Treatment of Patients With High Risk Localized Prostate Cancer